As the Account Director at Indegene, she manages and expands a portfolio featuring two of the world’s largest biopharmaceutical companies. Specializing in digital services, she leverages AI/Gen AI, ML, and NLP to enhance efficiency and streamline solutions in medical affairs, regulatory affairs, pharmacovigilance, safety, clinical research, and development. 

Her extensive expertise spans Competitive Intelligence, Market Research, Management Consulting, Market Access, Commercial Strategy, and Business Development. Having worked for top multinationals such as Bayer Healthcare and Frost and Sullivan, she serves as a subject-matter expert, consulting with biopharma clients globally.

With over 75 publications, including market research reports and thought-leader interviews for reputable industry publications, she is always recognized internationally. She has authored syndicated reports on topics like Generics, Biosimilars, and Biopharmaceutical Contract Manufacturing, cited extensively in global trade publications, and presented as a keynote speaker at international conferences. 

Ms. Aiswariya Chidambaram’s standing within the global Biopharmaceutical industry has garnered acknowledgment, leading to the conferment of the “Alien of Extraordinary Ability” permanent residency status by the U.S. Government. She is also featured as an honored listee of the prestigious Marquis Who’s Who in America 2023. She is committed to fostering the next generation of female STEM leaders, she serves as the Vice-Chair for the Young Women in Bio Committee (YWIB) within the WIB Capital Region Chapter. 

She dedicates herself to inspiring and supporting young women through educational resources, hands-on experiences, career guidance, and impactful programs in collaboration with leading organizations. Ms. Aiswariya’s success story is not only marked by professional achievements but also by her dedication to empowering and inspiring future leaders in STEM.